DOJ Targets Hochul Administration Over Manhattan Medicaid Bid Rigging, $11 Billion at Stake

The federal probe into New York’s $11 billion Medicaid homecare overhaul threatens to upend policymaking, shake political alliances, and expose the perils of reform-by-decree in America’s largest city.

Eleven billion dollars is a formidable sum—even for New York, a metropolis that measures its municipal budgets in the tens of billions. Yet that is the figure now under federal scrutiny as the US Department of Justice (DOJ) prepares a lawsuit against Governor Kathy Hochul’s administration, challenging the recent reshaping of New York State’s Medicaid homecare system. The storm centres on how a single company, Public Partnerships LLC (PPL), came to control the payroll of tens of thousands of home health aides overnight.

The DOJ’s formal complaint, expected imminently, will cast a long shadow over not only Hochul’s staff and the leadership at the state Department of Health but also the broader integrity of New York’s public contracting. Sources intimate with the investigation cite “bid rigging” and “non-compliance with Medicaid billing rules” among the allegations—hardly trivial concerns for a sector that cares for New Yorkers’ most vulnerable.

For the city’s one million Medicaid enrollees, and particularly the elderly and disabled relying on home-based care, the stakes are palpable. The Consumer Directed Personal Assistance Program (CDPAP), designed to let recipients hire aides—often family members—for care at home, has ballooned in scale and cost. In 2024, arguing pervasive fraud and inefficiency, Hochul’s administration moved to purge hundreds of payroll middlemen and consolidate operations under a single vendor. The intent: streamline, save, and suppress abuse.

But in its haste, Albany may have courted bigger trouble. Watchdogs point to damning emails unearthed by the Empire Center for Public Policy, in which senior health officials and Hochul aides coordinated directly with PPL on implementation details weeks before competitive bidding had formally begun. Medicaid Director Amir Bassiri and Deputy Secretary Angela Profeta were both caught in the crossfire, with Bassiri later serving on the panel to score the contract—a revolving role that, at best, undermines public trust.

The political temperature rose modestly higher when PPL admitted, after earlier denials, that it had indeed conversed with the Hochul administration before submitting its proposal. This revelation, set against aggressive unionization drives by 1199SEIU—the powerful healthcare union—paints a picture of policymaking that is, if nothing else, far from insulated from interest group pressure.

The consequences for New York City are profound. Thousands of aides’ pay, protections, and union status now hinge on a contract over which questions linger. Families worry about interruptions in care should litigation paralyse operations, while independent payroll agencies face extinction. More abstract, but no less material, is the potential for further erosion of faith in City and State Hall’s ability to manage sprawling welfare programs fairly.

For the city’s political class, the second-order implications portend a cooling of the reformist zeal that has animated recent Medicaid changes. Should the DOJ’s suit prevail, lawmakers may grow gun-shy about sweeping administrative reforms, preferring incrementalism to big-bang restructuring. Union chiefs, emboldened by victory in centralising payroll, might push harder for even greater carve-outs in future deals—though now tantalised by the scent of scandal, rivals will scrutinise every step.

The economic stakes are considerable. An $11 billion contract—at a time of post-pandemic belt-tightening—offers a tempting morsel for private contractors and campaign donors alike. If the DOJ’s allegations stick, future bidders may regard city- and state-level tenders as less contestable, chilling competition and driving up costs. For taxpayers, such opacity bodes ill; for the 220,000 New Yorkers employed as home health aides, it may mean less stability and transparency about their benefits.

New York is, hardly for the first time, something of a bellwether. Nationwide, states are wrestling with how to control spiralling Medicaid expenditures without gutting long-term care. Consolidating vendors is not unique to Albany; California and Illinois have tried—sometimes to greater public rancour, sometimes to less. What distinguishes New York is the sheer scale, the tightknit web of union politics, and the city’s perennial role as laboratory for American welfare policy.

Public trust on the line, as policy meets politics

In this sense, the looming legal duel offers a warning to those tempted by the allure of “efficiency” secured by fiat. The American model for social provision—fragmented, messy, and prone to favouritism—often scorns the virtues of patience and transparency. Even the most well-intentioned reforms risk being undermined by the time-honoured practices of political horse-trading and insider negotiation.

Neither Governor Hochul nor PPL face certain downfall. History offers examples of similar contractual imbroglios resolved by hasty settlements, handwringing apologies, and—most importantly—no lasting change. Still, the DOJ’s intervention signals that Washington is willing to act when local ambitions outstrip public process, and that even the city that never sleeps must heed the rules of procurement.

We reckon the episode bodes poorly for the city’s immediate efforts to mend its tattered social contract. Yet some dry comfort may be found in the scrutiny itself. There is virtue in exposure, if it checkmates further excesses and prompts more arms-length dealings in Albany. New Yorkers—somewhat fatalistically—expect a modicum of grift in governance, but also prefer their scandals to illuminate as well as entertain.

If there is hope for New York’s homecare system, it lies in process, not personality: competitive bidding that is actually competitive, oversight bodies that bite as well as bark, and administrative ambition tempered by procedural modesty. Data, not deals, must guide future reforms. Whether Washington’s lawsuit serves as a corrective or yet another footnote in the annals of Gotham’s political escapades remains to be seen. For now, New Yorkers can expect a lively year ahead—as Medicaid’s billions attract not only aides and administrators, but also, inevitably, a bevy of lawyers.

■